Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice

GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN

Bernhard Kreymann, Mohammad A. Ghatei, Gareth Williams et al. · The Lancet · 1987 · 1.9K citations

Molecular Physiology, Physiology, Glucagon-like Peptide-1 7-36 +5

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

Gang Xu, Doris A. Stoffers, Joel F. Habener et al. · Diabetes · 1999 · 1.2K citations

Glucose Tolerance, Cellular Physiology, Insulin Signaling +19

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Arne Astrup, Stephan Rössner, Luc Van Gaal et al. · The Lancet · 2009 · 1.1K citations

Obesity, Nutrition, Metabolic Syndrome +6

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier et al. · Gastroenterology · 2011 · 911 citations · Full text

Pancreatic Cancer, Medicine, Pathology +4

Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

Lazaros A. Nikolaidis, Sunil Mankad, George Sokos et al. · Circulation · 2004 · 895 citations